Fibroblast growth factor 18 attenuates liver fibrosis and HSCs activation via the SMO-LATS1-YAP pathway.
Tong G, Chen X, Lee J, Fan J, Li S, Zhu K, Hu Z, Mei L, Sui Y, Dong Y, Chen R, Jin Z, Zhou B, Li X, Wang X, Cong W, Huang P, Jin L.
Tong G, et al. Among authors: li s, li x.
Pharmacol Res. 2022 Apr;178:106139. doi: 10.1016/j.phrs.2022.106139. Epub 2022 Feb 21.
Pharmacol Res. 2022.
PMID: 35202822